Inventor · disambiguated record
Christian Auclair
Also filed as: AUCLAIR CHRISTIAN
10 granted patents·10 pending applications·54 citations·filing 1998–2021
84Inventor score
Top patents by PatentIndex Score
20 records- 0189US8828718B2Gene transfer vectors comprising genetic insulator elements and methods to identify genetic insulator elementsCOHEN-HAGUENAUER ODILE·Filed 2010·Granted Sep 9, 2014·19 cites·13 claims
- 0281US9271956B2Companion cosmetic compositionsBIONOOX SUISSE SA·Filed 2013·Granted Mar 1, 2016·8 cites·16 claims
- 0375US6670377B1Quinoline derivatives, having in particular antiviral properties, preparation and biological applications thereofCENTRE NAT RECHERCHE·Filed 1998·Granted Dec 30, 2003·25 cites·12 claims
- 0464US9956200B2Compositions comprising dihydroquercetin for use in methods for treating the effects associated with skin inflammatory disordersBIONOOX SUISSE SA·Filed 2015·Granted May 1, 2018·1 cites·18 claims
- 0559US8227433B2Use of inhibitors and antisense oligonucleotides of BTK for treating proliferative mastocytosisAUCLAIR CHRISTIAN·Filed 2004·Granted Jul 24, 2012·1 cites·17 claims
- 0655US2009286720A1Pharmaceutical composition for the diagnosis, prevention or treatment of a tumoral pathology comprising an agent modulating the polymerization state of actinBIOALLIANCE PHARMA·Filed 2009·Application pending·0 cites
- 0750US11077087B2Compositions comprising dihydroquercetin for use in methods for treating herpesBIONOOX SUISSE SA·Filed 2016·Granted Aug 3, 2021·0 cites·8 claims
- 0849US2023355749A1Immunomodulatory Compounds And Use Thereof For The Treatment And/Or Prevention Of Infectious DiseasesAC BIOSCIENCE SA·Filed 2021·Application pending·0 cites
- 0946US2023121797A1A combination of flavonoids and sphingosine 1 phosphate lyase inhibitors for the treatment of lung inflammationAC BIOSCIENCE SA·Filed 2021·Application pending·0 cites
- 1045US11850234B2Enhancement of cancer treatment efficiency via the sphingosine-1-phosphate pathwayAC BIOSCIENCE·Filed 2018·Granted Dec 26, 2023·0 cites·8 claims
- 1145US2004191230A1Pharmaceutical composition for the diagnosis, prevention or treatment of a tumoral pathology comprising an agent modulating the polymerization state of actinBIOALLIANCE PHARMA A CORP OF F·Filed 2003·Application pending·0 cites
- 1243US11351146B2Topical compositions for the treatment of cutaneous leishmaniasisAC BIOSCIENCE SA·Filed 2018·Granted Jun 7, 2022·0 cites·14 claims
- 1343US2022306587A1Compounds and use thereof for the treatment of infectious diseases and cancerAC BIOSCIENCE SA·Filed 2020·Application pending·0 cites
- 1443US2022265670A1Composition and use thereof for the treatment of cutaneous mastocytosisAC BIOSCIENCE SA·Filed 2020·Application pending·0 cites
- 1542US2021113518A1Composition And Use Thereof Against Drugs Induced PhototoxicityAC BIOSCIENCE SA·Filed 2019·Application pending·0 cites
- 1642US2022142994A1Beta-Carboline Compounds And Use Thereof For The Non-Cytotoxic And Immunological Treatment Of CancerAC BIOSCIENCE SA·Filed 2020·Application pending·0 cites
- 1742US2021113523A1Compositions For Treating And/Or Preventing Photodynamic Therapy Side EffectsAC BIOSCIENCE SA·Filed 2019·Application pending·0 cites
- 1840US10383955B2Human mast cell lines, preparation and usesCENTRE NAT RECH SCIENT·Filed 2012·Granted Aug 20, 2019·0 cites·5 claims
- 1938US7491505B2Method for analyzing tumor aggressivity comprising measurement of polymerized actinBIOALLIANCE PHARMA·Filed 2003·Granted Feb 17, 2009·0 cites·10 claims
- 2034US2009197906A1Reversion of malignant phenotype with 9-hydroxy ellipticine derivativesAUCLAIR CHRISTIAN·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →